Application 212945
- Type
- ANDA
- Sponsor
- AMNEAL EU LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | VASOPRESSIN | VASOPRESSIN | INJECTABLE;INJECTION | 200UNITS/10ML(20UNITS/ML) | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| VASOPRESSIN | VASOPRESSIN | HF Acquisition Co LLC, DBA HealthFirst | 53372911-5a55-dfac-e063-6394a90ae2f6 | 2026-07-21 | Warnings, Adverse reactions | VASOPRESSIN VASOPRESSIN |
| VASOPRESSIN | VASOPRESSIN | HF Acquisition Co LLC, DBA HealthFirst | 5232a8bc-d7ae-48a5-e063-6294a90a76ca | 2026-07-21 | Warnings, Adverse reactions | VASOPRESSIN VASOPRESSIN |
| VASOPRESSIN | VASOPRESSIN | HF Acquisition Co LLC, DBA HealthFirst | 52324969-4536-2b7c-e063-6394a90a9b4d | 2026-07-10 | Warnings, Adverse reactions | VASOPRESSIN VASOPRESSIN |
| Vasostrict | VASOPRESSIN | Par Health USA, LLC | b1147beb-743e-4c62-8927-91192447f8b8 | 2026-04-21 | Warnings, Adverse reactions | VASOPRESSIN |
| Vasostrict | VASOPRESSIN | Par Health USA, LLC | b97e5c3e-ca28-4ffa-80af-6c5bdbadaf10 | 2026-04-16 | Warnings, Adverse reactions | VASOPRESSIN |
| VASOPRESSIN | VASOPRESSIN | ProPharma Distribution | 386a8e67-1f18-6513-e063-6294a90a5ffe | 2025-12-18 | Warnings, Adverse reactions | VASOPRESSIN VASOPRESSIN |
| VASOPRESSIN | VASOPRESSIN | Eugia US LLC | eadd82d7-e2cb-4144-9f0c-b340f54c6fa4 | 2025-10-24 | Warnings, Adverse reactions | VASOPRESSIN VASOPRESSIN |
| Vasopressin | VASOPRESSIN | Gland Pharma Limited | 971f9b1c-6094-4f80-920b-cb5d7e62950a | 2025-08-26 | Warnings, Adverse reactions | Vasopressin VASOPRESSIN |
| VASOPRESSIN | VASOPRESSIN | HF Acquisition Co LLC, DBA HealthFirst | f5f03364-e71c-9bcd-e053-2995a90a8ada | 2025-07-11 | Warnings, Adverse reactions | VASOPRESSIN VASOPRESSIN |
| Vasopressin in 0.9% Sodium Chloride | VASOPRESSIN | Long Grove Pharmaceuticals, LLC | bf4b0b63-0055-40d8-b331-7f9f1ea3214c | 2025-06-17 | Warnings, Adverse reactions | VASOPRESSIN |
| vasopressin | VASOPRESSIN | Medical Purchasing Solutions, LLC | 3532868c-ac1d-43c8-e063-6394a90a4fd1 | 2025-05-15 | Warnings, Adverse reactions | vasopressin VASOPRESSIN |
| Vasopressin | VASOPRESSIN | Civica, Inc. | cce1a220-3178-49ec-b046-f0cb134cf051 | 2025-03-01 | Warnings, Adverse reactions | Vasopressin VASOPRESSIN |
| VASOPRESSIN | VASOPRESSIN | Fresenius Kabi USA, LLC | 50aef1e8-0a70-466d-93cd-c1b9ed489839 | 2025-02-27 | Warnings, Adverse reactions | VASOPRESSIN VASOPRESSIN |
| VASOPRESSIN | VASOPRESSIN | Fresenius Kabi USA, LLC | 04e0c406-6b49-4c0b-abc5-9a1a75532485 | 2025-02-15 | Warnings, Adverse reactions | VASOPRESSIN VASOPRESSIN |
| Vasopressin | VASOPRESSIN | Sagent Pharmaceuticals | ad3ac280-49da-4816-9097-14517d0c0f85 | 2024-11-09 | Warnings, Adverse reactions | Vasopressin VASOPRESSIN |
| Vasopressin | VASOPRESSIN | American Regent, Inc. | 0ab267f4-9ec9-44fd-8521-f975074667d9 | 2024-10-31 | Warnings, Adverse reactions | Vasopressin VASOPRESSIN |
| vasopressin | VASOPRESSIN | Dr. Reddy's Laboratories, Inc. | caf04d72-679e-daf9-e86f-4867f83b8ac5 | 2024-07-31 | Warnings, Adverse reactions | vasopressin VASOPRESSIN |
| vasopressin | VASOPRESSIN | Amneal Pharmaceuticals LLC | d9869345-b02c-4225-a97b-656f14c86dec | 2024-07-07 | Warnings, Adverse reactions | vasopressin VASOPRESSIN |
| VASOPRESSIN | VASOPRESSIN | Eugia US LLC | 85e3dc1e-98ae-4c4c-8af9-237375475e08 | 2023-11-07 | Warnings, Adverse reactions | VASOPRESSIN VASOPRESSIN |
| VASOPRESSIN | VASOPRESSIN | Medical Purchasing Solutions, LLC | 0933a550-03f1-0937-e063-6394a90a1e89 | 2023-11-02 | Warnings, Adverse reactions | VASOPRESSIN VASOPRESSIN |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 72044 | ORIG | 2022-09-08 |